Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Short-Term Debt repayments (2016 - 2023)

Lifecore Biomedical, Inc. \De\ has reported Short-Term Debt repayments over the past 12 years, most recently at $12.2 million for Q2 2023.

  • For Q2 2023, Short-Term Debt repayments rose 22.4% year-over-year to $12.2 million; the TTM value through May 2023 reached $54.6 million, up 23.87%, while the annual FY2024 figure was $146.7 million, 168.49% up from the prior year.
  • Short-Term Debt repayments for Q2 2023 was $12.2 million at Lifecore Biomedical, Inc. \De\, down from $41.6 million in the prior quarter.
  • Over five years, Short-Term Debt repayments peaked at $95.0 million in Q1 2021 and troughed at $800000.0 in Q4 2022.
  • A 5-year average of $22.1 million and a median of $17.0 million in 2019 define the central range for Short-Term Debt repayments.
  • Biggest five-year swings in Short-Term Debt repayments: surged 1033.33% in 2019 and later tumbled 90.0% in 2022.
  • Year by year, Short-Term Debt repayments stood at $37.0 million in 2019, then tumbled by 86.49% to $5.0 million in 2020, then soared by 60.0% to $8.0 million in 2021, then tumbled by 90.0% to $800000.0 in 2022, then skyrocketed by 1430.0% to $12.2 million in 2023.
  • Business Quant data shows Short-Term Debt repayments for LFCR at $12.2 million in Q2 2023, $41.6 million in Q1 2023, and $800000.0 in Q4 2022.